Pharmaceutical and medical research provides new and innovative treatments to enhance well being and prosperity. Pharmaceutical R&D, as well as product and medical devices manufacturing is a technically demanding industry, and uses vacuum technologies in various key applications.
A variety of vacuum instruments, such as dry vacuum pumps, turbomolecular leak detectors, vacuum gauges and segments are utilized to streamline performance across applications, going from light duty to the heaviest forms.
Edwards Vacuum, a leading manufacturer of sophisticated vacuum products and abatement systems and a leading provider of related value-added services, is now offering the CXS range of dry pumps, which delivers exceptional vacuum performance in pharmaceutical processes.
The introduction of the CXS range comes at a time when China’s pharmaceuticals industry is on the move, driven by domestic reforms in healthcare and a determination to sink major investment into biotechnology and the development of new drugs. Edwards is determined to be part of the action, with its innovative dry pump technology ideally suited to the stringent demands of pharmaceutical production processes.
“Vacuum is central to pharmaceutical production,” noted Neil Lavender-Jones, President, Asia Pacific, Edwards. “China’s burgeoning pharmaceuticals market is expected to be the second largest in the world, after the US, by 2015. If China is going to achieve its ambitious reform and investment programs, its pharmaceutical sector will need the dry pump technology we offer, together with our wealth of experience in vacuum chemical processes and our ability to work with the customer to find the vacuum solution that’s exactly right for them.”
